IDH2 and breast carcinoma: PHGDH and possibly other sources, such as ADHFE1, besides the nonmutant IDH2 (155) and IDH1 are responsible for elevated 2HG levels in breast carcinoma in the absence of the IDH1/2 mutant enzymes (166, 168).